Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Cancer|July 11, 1998
A phase II trial of 5-fluorouracil, leucovorin, and carboplatin in patients with unresectable biliary tree carcinomaP M Sanz-Altamira, K Ferrante, R L Jenkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
Paclitaxel for platinum-refractory ovarian cancer: results from the first 1,000 patients registered to National Cancer Institute Treatment Referral Center 9103E L Trimble, J D Adams, D Vena, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2001
Cardiac function following combination therapy with paclitaxel and doxorubicin: an analysis of 657 women with advanced breast cancerL Gianni, P Dombernowsky, G Sledge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I studyG G Chabot, J P Armand, C Terret, et al.
British Journal of Cancer|July 17, 1998
Phase I study of the mitomycin C analogue BMS-181174V M Macaulay, K J O'Byrne, J A Green, et al.
Cancer Research|April 1, 1986
Phase I study of ethylenediamine platinum(II) malonate (NSC 146 068), a second generation platinum analogueB Winograd, J B Vermorken, W W ten Bokkel Huinink, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Phase I study of Brequinar sodium (NSC 368390) in patients with solid malignanciesG Schwartsmann, P Dodion, J B Vermorken, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcomaP S Gill, A Tulpule, B M Espina, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancerJ F Bishop, J Dewar, G C Toner, et al.
Seminars in Oncology|August 1, 1995
High-dose paclitaxel with granulocyte colony-stimulating factor in patients with advanced breast cancer refractory to anthracycline therapy: a European Cancer Center trialJ B Vermorken, W W ten Bokkel Huinink, I A Mandjes, et al.
Pageof 7